Bone marrow transplantations between wild-type and Fpr2-/- mice and myeloid-specific Fpr2 deletion demonstrated that Fpr2-expressing myeloid cells exacerbated HFD-induced obesity, IR, glucose/lipid metabolic disturbances, and inflammation [14]. The gene discussed is FPR2; the disease is Obesity.